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INTRODUCTION
Pulmonary hypertension (PH) is a rare and progressive dis-
ease that is associated with poor prognosis. According to
the clinical classification of pulmonary hypertension, there
are five clinical groups of PH (Piazza and Goldhaber,
2011). Specific drug therapy is available for only two of
these groups — Group 1 Pulmonary arterial hypertension
(PAH) and Group 4 Chronic thromboembolic pulmonary
hypertension (CTEPH) (Becatini et al, 2006).
CTEPH is defined as mean pulmonary artery pressure
higher than 25 mm Hg that persists for six months after pul-
monary embolism (PE) is diagnosed (Piazza and Goldhaber,
2011). It is caused by organised thrombi in the pulmonary
arteries as the result of non-resolving thromboemboli, for-
mation of fibrosis and remodeling of pulmonary blood ves-
sels (Galie et al., 2009)
Currently, the following specific drug therapy is used for
the treatment of PAH: calcium channel blockers, prosta-
noids, endothelin receptor antagonists, phosphodiesterase
type-5 inhibitors and soluble guanylatecyclase stimulators
(Galie et al., 2009; Ghofrani et al., 2013). For treatment of
CTEPH only one specific drug therapy is available — solu-
ble guanylatecyclase stimulators (Ghofrani et al., 2013). Al-
though results vary, it has been established that CTEPH oc-
curs in 1 to 4% of patients after acute PE (Pengo et al.,
2004; Becattini et al., 2006; Tapson and Humbert, 2006). It
is almost impossible to determine the overall prevalence of
CTEPH, since not all patients with CTEPH have a history
of acute PE (Galie et al., 2009). Even though PE may be
asymptomatic, there is accumulating evidence that CTEPH
may also develop in the absence of previous pulmonary em-
bolism (Hoeper et al., 2006).
Even nowadays, with good diagnostic feasibility, as the
symptoms are not disease-specific, CTEPH is under-diag-
nosed and under-treated, which is shown by statistical stud-
ies (Blauwet et al., 2003).
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Chronic thromboembolic pulmonary hypertension (CTEPH) occurs in 1 to 4% after acute pulmo-
nary embolism. CTEPH can be cured by pulmonary endarterectomy (PEA), which is approved
golden standard in chronic condition. There were performed three cases of PEA in Latvian Cardi-
ology Centre during 2013–2014. General anaesthesia under cardiopulmonary bypass (CPB) with
deep hypothermic circulatory arrests was provided. The core issue is correct patient selection (in
terms of central PA obstruction by thrombus) as well as pulmonary circulation recovery capacity.
Neuroprotection was provided by deep hypothermia, topical cooling of the head, Trendelenburg
position, mild hypocapnia, Hb 9–10 g/L and pharmacological agents. For screening postoperative
cognitive function the mini mental state examination (MMSE) was used before and after the sur-
gery. Postoperative pulmonary vascular resistance index decreased by 56.3% (right ventricular
systolic pressure decreased from 93.3 ± 25.7 to 44.5 ± 11.2 mmHg). Before the surgery three pa-
tients had NYHA functional class III or IV, at the time of discharge — I or II. In one case moderate
(MMSE 18) cognitive disorders was observed at discharge from the ICU. No one died neither in
the hospital nor within 30 days of discharge. The surgery improved RV function and pulmonary
perfusion with no considerable organ failure, except mild cognitive disorders.
Key words: pulmonary endarterectomy, neuroprotection, cardiac bypass, pulmonary hyperten-
sion, neurocognitive dysfunction.
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CTEPH can be sub-classified into operable and inoperable
forms. Inoperability can be caused by occlusion of distal
vessels, patient comorbidities, refusal to undergo surgery,
and also inaccessibility of expert surgical centres (Mayer et
al., 2011). Surgical pulmonary endarterectomy (PEA) is the
therapy of choice and is the only potentially curative treat-
ment for patients with surgically accessible CTEPH, as it
leads to a profound improvement in haemodynamics, func-
tional class and survival. (Mayer et al., 2011). The first suc-
cessful bilateral PEA was performed in 1963 by Houk et al.
(Houk et al., 1963).
PEA is a complex procedure. It is performed by experi-
enced specialists, and post-operation mortality can be as
high as 5% (Mayer et al., 2011). Patient selection is of great
importance. It is necessary to evaluate haemodynamic im-
provement, which can be achieved post-operatively. Some
authors believe that the PEA should only be performed if
predicted decrease of pulmonary vascular resistance after
performing PEA is greater than 50% (Dartevelle et al.,
2004; Keogh et al., 2009).
The aim of the study was to demonstrate anaesthesia man-
agement with deep hypothermia and circulatory arrest for
pulmonal endarterectomy.
MATERIALS AND METHODS
During 2013–2014, we performed three PEA in Pauls
Stradins Clinical University Hospital, Latvian Cardiology
Centre. Perioperative routinely collected patient data were
analyzed, after the permission by the Ethics Committee for
the publication of the medical research had been obtained.
Clinically suspected diagnosis was confirmed by pulmonary
artery CT angiography with contrast, cardiac catheterisation
and transthoracic echocardiography. All the data were col-
lected prospectively. Preoperative pulmonary artery pres-
sure, cardiac index and pulmonary vascular resistance were
measured prior to surgical incision. In the postoperative pe-
riod the same values were compared after 24 h. Standard
perioperative monitoring included invasive arterial blood
pressure measurements, Swan-Ganz catheter for pulmonary
artery pressures, once daily chest X-ray, 2D-ECHO and ar-
terial blood gases. The surgery was performed with extra-
corporeal circulation, deep hypothermia 18 °C, with several
periods of total circulatory arrest, in order to facilitate the
extraction of the thrombi from pulmonary artery branches.
The patients main diagnosis was CTEPH III functional
class. Heart failure was the NYHAIII-IV functional class.
The mini mental state examination (MMSE) was used
for screening postoperative cognitive function. Neuro-
cognitive status was assessed before and after the surgery
(tl — first postoperative day, t2 — time of discharge from
the ICU).
Surgical technique. PTEAE was performed from the peri-
cardium and the pleural space was not entered in standard
cardiac surgical approach via median sternotomy. Dissec-
tion was made within the superficial layer of the vessel
wall, mobilising the inner part of the vessel containing
thrombi and scar tissue. The right pulmonary artery was ex-
posed between aorta and the vena cava superior, and an in-
cision was made starting medially and extending beneath
the mobilised vena cava superior, but not extending outside
the pericardium. Very good visibility is required in a blood-
less field to define an adequate endarterectomy plane, and
periods of circulatory arrest are necessary because of exces-
sive bronchial blood flow that is usually present. During the
episodes of circulatory arrests, dendritically organised
thrombi from the right and left pulmonary arteries and their
branches were removed (Fig. 1). After surgery patients were
referred to the Intensive Care Unit of Cardiac Surgery for
successful recovery.
Anaesthesia management. General anaesthesia under CPB
with deep hypothermic circulatory arrests for the safe surgi-
cal approach was provided (Fig. 2). Perioperative monitor-
ing included: invasive arterial and central venous pressures
measurement, measurements of continuous cardiac output
(CCO), pulmonary and systemic vascular resistances
(PVRI, SVRI) and mixed venous oxygen saturation (SvO2).
Arterial blood gas analysis was performed every 10–30
minutes to estimate glucose, lactate, sodium and potassium
levels as well as to monitor mild hypocapnic ventilation. Bi-
lateral constant measurements of regional cerebral oxygen
saturation (SrO2) were provided. Urine output in ml per
hour and the difference of core body temperature (Celsius,
°C) was measured in rectum and oesophagus. Trans-
oesophageal echocardiography was performed to evaluate
anatomical structures of the heart and blood flow in aorta.
Anaesthesia was induced by ketamine 0.75 mg/kg, fentanyl
3 mkg/kg and etomidate 0.2 mg/kg intravenously (i.v.).
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Fig. 1. Thrombus removed from left
and right pulmonàry arteries.
Cisatracurium 0.15 mg/kg was used for muscle relaxation.
Mechanical lung ventilation was provided in pressure regu-
lated volume control mode. Anaesthesia was maintained
with sevoflurane administered at MAC 0.8–1.0. During
CPB, anaesthesia was maintained with fentanyl 0.05
g/kg/min, propofol 75 g/kg/min and cisatracurium 1
g/kg/min i.v. Standard pulsatile CPB with an extra-
corporeal circuit consisting of a polypropylene membrane
oxygenator with deep hypothermia (rectal temp. 18 °C) was
used. Before the start of CPB, heparin was administered in a
dose of 25 000 units to achieve and maintain activated clot-
ting time above 480 seconds during CPB. The blood was
cooled by a pump-oxygenator. During cooling, a 10 °C gra-
dient between blood and bladder or rectal temperature was
maintained. Cooling in total took nl — 45, n2 — 55, n3 —
48 minutes. After completion of endarterectomy, CBP was
resumed and warming was commenced. During warming a
10 °C temperature gradient was maintained between the
perfusate and body temperature. The rewarming period in
total took approximately nl — 84, n2 — 94, n3 — 89 min,
but varied according to the body mass of the patient. When
the patient had been rewarmed to a rectal temperature of
at least 36 °C, the CPB was discontinued. After weaning
from CPB, protamine was administered i/v in a dose of 1
mg per 100 units of heparin. Despite the duration of CPB,
haemostasis was readily achieved, and the administration of
platelets or coagulation factors was generally unnecessary.
During the surgery normovolemic haemodilution was main-
tained. Much efforts was applied to provide cerebral protec-
tion during the surgery. Therefore, deep hypothermia, local
ice applications on the head, Trendelenburg position, mild
hypocapnia (arterial blood pCO2 29–32 mmHg) and haemo-
globin around 9–10 g/L were maintained. To reduce cere-
bral blood flow, i. e. to reduce cerebral oxygen consump-
tion, Thiopental 500 mg  3 i.v. was administered before
each circulatory arrest. Methylprednisolone 250 mg i.v. was
given after aortic occlusion and before reperfusion to de-
crease systemic inflammatory response, which can aggra-
vate ischemia-reperfusion injury. Additionally, 250 ml 15%
mannitol solution was added in the CPB system during
reperfusion to reduce cerebral oedema.
Postoperative care. The postoperative course was charac-
terised by a marked increase in cardiac output, with a con-
comitant decrease in pulmonary artery pressures and PVR
both immediate and sustained. (Blauwet et al., 2003) Pa-
tients were generally mechanically ventilated for at least 24
hours with a maximal inspiratory pressure maintained be-
low 30 cm of water. The fractional inspired oxygen level
was kept as low as possible, ensuring an oxygen saturation
of over 90%, and the haematocrit level was kept about
27–30–33%. To prevent rethrombosis and reocclusion of
the pulmonary arteries after surgery, intravenous heparin in-
fusion was started within eight hours, followed by subcuta-
neous low molecular weight heparin on the evening of sur-
gery, then by anticoagulation with warfarin as soon as the
pacing wires and mediastinal drainage tubes were removed.
RESULTS
The mean patient age was 46 years, with a range of 31 to
67. The mean total cardiopulmonary bypass time was 251 ±
40 min; in one case circulation was stopped twice (24/20
min), and in two cases three times (20/28/8 and 26/17/29
min). The mean aortic cross clamp time was 114 ± 21 min
and mean intermittent circulatory arrest time was 21.5 ± 6.9
min. Average rectal temperature during deep hypothermia
was 19.1 ± 2.1 °C. The mean preoperative right ventricular
systolic pressure was 93.3 ± 25.7 mmHg, and postoperative
44.5 ± 11.2 mmHg. Total cardiopulmonary bypass time cor-
related with body mass and cooling-rewarming intervals.
After surgery a reduction in PA pressures and PVRI to nor-
mal levels, corresponding improvement in pulmonary blood
flow and CO were generally immediate and sustained
(PVRI reduction from 541 ± 33.9 to 236.5 ± 81.3, by
56.3%).
Cerebral protection was monitored with cerebral oximeter
INVOS monitoring (Fig. 3) of SrO2, which had to be equal
on the left and right sides. The lowest acceptable limit for
SrO2 is 40% (Fig. 2). Before starting CPB, SrO2 was equal
on both sides, right — 69 ± 5% and left side 70 ± 7%, re-
spectively. The lowest values of SrO2 during the first circu-
latory arrest were 38 ± 7% and 44 ± 8%, while in the sec-
ond circulatory arrest — 30 ± 3% and 28 ± 4%. At those
moments circulation was restored shortly until SrO2 turned
back to the baseline. In the third circulatory arrest SrO2 val-
ues were within normal ranges — 70 ± 6% and 68 ± 7%.
During weaning from CPB, SrO2 values were within normal
range at 74 ± 6% and 71 ± 5% in right and left sides. In one
our case cognitive disorders was observed postoperatively
at discharge from the ICU (MMSE 18 points — moderate
cognitive impairment). Measurements of lactate, glucose,
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Fig. 2. Cardiopulmonary bypass with deep
hypothermic circulatory arrests.
potassium and sodium levels are essential to evaluate tissue
perfusion and acidosis. In the present case the maximum se-
rum lactate level was 5.0 ± 1.3 mmol/L during the
reperfusion period. In parallel, acidosis is accelerated in the
presence of hyperglycaemia, which compounds ischemic
cerebral injury. Therefore, the glucose level was maintained
below 10 mmol/L. Before the surgery, three patients had
NYHA functional class III or IV, at the time of discharge
their NYHA functional class had turned to I or II. Echo-
cardiographic studies have demonstrated that with the elimi-
nation of chronic pressure overload, right ventricular geom-
etry rapidly reverts to normal. In general, right atrial and
right ventricular hypertrophy and dilation regressed after
operation. The median stay in ICU for all patients was three
days, and the median duration of intubation was 24 hours.
The median length of hospital stay postoperatively was 16
days. No patient died, neither in the hospital nor within 30
days of discharge. The rates of perioperative neurcognitive
dysfunction for PTE were similar to those seen with con-
ventional open heart surgery. Successfully performed PTE
led to significant reduction of right ventricular chamber size
and improved RV systolic pressure. PVRI, SVRI, brain
natriuretic peptide may be considered as good markers for
efficacy of PEA.
DISCUSSION
The greatest challenge of general anaesthesia during
CTEAE is to manage deep hypothermic circulatory arrest,
which can lead to tissue hypoxia (Blauwet et al., 2003;
Pengo; et al., 2004). Deep hypothermia during circulatory
arrest significantly decreases brain metabolism (by 15%)
and oxygen demand; the latter helps to reduce anaerobic
glycolysis and accompanying acidosis (Dalen and Alpert,
1975; Corsico et al., 2008).
Therefore, deep hypothermia is essential during PTEAE, as
it prolongs brain tolerance to ischemia up to 60 minutes
(Ishida et al, 2012). In the present cases, both pharmacolog-
ical and non-pharmacological methods for brain protection
were used. Additionally, low-flow CPB between circulatory
arrests was used to augment brain protection (Kumral et al.,
2001; Keogh et al., 2009). Pharmacological protection was
achieved by using barbiturates, propofol, steroids and
mannitol. Although steroids might lead to glucose metabo-
lism alterations, their role in decreasing proinflammatory
cytokines, which are thought to play a role in brain ischemic
injury, is pivotal. Disadvantages of deep hypothermic circu-
latory arrests are prolonged CPB time, which increases risk
of coagulopathy, and reperfusion syndrome inducing oe-
dema. Therefore, relative hypovolemia was maintained (Pi-
azza and Goldhaber, 2011; Ozsu and Cinarka, 2013)
Neurological disorders caused by imperfect cerebral protec-
tion during CPB with deep hypothermic circulatory arrest
may be present in the postoperative period. In the early days
of PTE there was a substantial incidence of postoperative
delirium with incidence of 3–12%. This can significantly af-
fect patient outcome (Becattini et al, 2006; Mayer et al,
2011). Studying the cognitive disorders after surgery is one
of the pressing issues nowadays. Cognitive and psychoemo-
tional disorders are associated with presence of general
pathogenetic factors (phenomenon of isolation and frontal
dysfunction) and directly influence each other. Only com-
bined neurocognitive and neuropsychological testing makes
it possible to define the presence and degree of the disor-
der's intensity. MMSE examination is not suitable for mak-
ing a diagnosis, but can be used to indicate the presence of
cognitive impairment. MMSE is far more sensitive in de-
tecting cognitive impairment than the use of informal ques-
tioning or overall impression of a patient's orientation.
Cerebral oximetry with the INVOS (IN Vivo Optical Spec-
troscopy) system provides the possibility of non-invasive,
continuous measurement of regional cerebral oxygen satu-
ration (rSO2), which can improve patient outcome (Ozsu
and Cinarka, 2013; Tian et al., 2013).
The cooling was done gradually, long enough to achieve
homogenous cooling of all organs. Ice packing on the head
enhanced cerebral hypothermia via conduction across the
skull. Moreover, it also helped to prevent an undesirable
rewarming of the brain during surgery. The rewarming
phase was longer than the cooling to avoid brain hyper-
thermia. Rewarming was stopped when core body tempera-
ture reached 36 oC (Svyatets et al, 2010).
Life-long anti-coagulation is mandatory. The administration
of iloprost six to eight times a day, with a single dose up to
25 mkg, has been described as more potent selective pulmo-
nary vasodilation, compared to NO inhalation, with superior
improvement in gas exchange (Kumral et al, 2001; Ozsu
and Cinarka, 2013). Recruitment manoeuvres and high posi-
tive end-expiratory pressure have been used to prevent
reperfusion pulmonary oedema, which develops in the ma-
jority of patients, but of variable degrees of severity. In
some rare cases extracorporeal membrane oxygenation has
been used to overcome this period of life-threatening pul-
monary oedema.
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Fig. 3. INVOS cerebral oximetry monitoring during deep hypothermic cir-
culatory arrests.
In conclusion, our experience in three cases of providing
general anaesthesia for PTEAE with deep hypothermic cir-
culatory arrests showed that it was relatively safe, without
cognitive disorders and hypoxemia-related complications in
the perioperative period. Moreover, it provided good condi-
tions for full extent surgical treatment.
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ANESTÇZIJA PIE PLAUÐU ARTÇRIJAS ENDARTEREKTOMIJAS DZIÏÂ HIPOTERMIJÂ AR CIRKULÂCIJAS APTURÇÐANU
Hroniska trombemboliska plauðu hipertensija (HTPH) ir plauðu hipertensijas forma ko sastop 1–4% pacientu pçc akûtas plauðu artçriju
trombembolijas. HTPH „zelta standarta” ârstçðanas metode ir plauðu endarterektomija (PEA). Latvijas Kardioloìijas centrâ 2013.–2014.
gadâ ir veiktas trîs PEA ar vispârçjo anestçziju mâkslîgajâ asinsritç (MAR) dziïâ hipotermijâ ar cirkulâcijas apturçðanu. Labvçlîgu operatîvo
iznâkumu nosaka pareiza pacientu atlase (pçc centrâla tipa plauðu artçriju obstrukcijas ar trombiem). Intraoperatîvi neiroprotekciju
nodroðinâja ar nefarmakoloìiskâm (dziïâ hipotermijâ, lokâla galvas dzesçðana, Trendelenburga pozîcija, viegla hipokapnija, Hb 9–10 g/L)
un farmakoloìiskâm metodçm. Pacientu neirokognitîvo funkciju pirms un pçc operâcijas izvçrtçja pçc MMSE skalas. Pçcoperâcijas
pulmonâlâs vaskulârâs rezistences indekss samazinâjâs par 56,3% (labâ kambara sistoliskais spiediens samazinâjâs no 93,3 ± 25,7 uz 44,5 ±
11,2 mm Hg). Pirms operâcijas NYHA FK bija III un IV, pçc — I un II. Izvçrtçjot neirokognitîvo funkciju, vienam pacientam konstatçja
vidçji smagu neirokognitîvu disfunkciju (MMSE 18 punkti). PEA ievçrojami uzlaboja labâ kambara funkciju un plauðu asinsriti, bez orgânu
mazspçjas pçcoperâcijas periodâ, izòemot vidçjas pakâpes neirokognitîvu disfunkciju vienam slimniekam.
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